Carta Healthcare Secures $18.25 Million for AI-Powered Clinical Data Solutions

Carta Healthcare has secured $18.25 million in Series B1 funding to advance its AI-powered clinical data abstraction and analytics services, announced in a press release. The investment round was led by UPMC Enterprises, with participation from several strategic investors, including MemorialCare Innovation Fund and Rex Health Ventures.

The funding will enable Carta Healthcare to expand its customer base, particularly in the life sciences sector, and enhance its AI-driven solutions that streamline clinical data abstraction. This comes after the company's acquisition of Realyze Intelligence, which uses AI to analyze structured and unstructured data for clinical trials and research studies.

Brent Burns, Executive Vice President at UPMC Enterprises, highlighted the importance of Carta Healthcare's technology in addressing the challenges of clinical data abstraction and patient trial matching. The investment aims to support the company's mission to provide actionable insights that improve patient care and operational efficiency in healthcare systems.